There are about 140 cannabinoids in the cannabis plant, with THC (the psychoactive component) and CBD, which has anti-inflammatory properties, of most interest to researchers. THC has also been linked to anxiety and mental health problems.CBD is the focus of much of Israel’s flourishing medical cannabis research on diabetes, heart disease, autism, fracture healing and inflammatory bowel disease. Isolated, CBD has the opposite effect, often calming people down, hence what makes it so appealing as a medicine.The former employee says Sharpton came down, greeted the singer in the lobby and brought him to her room.Bloom is currently attempting to subpoena the surveillance video that shows Usher going to the hotel room.
More than 50 US companies are doing medical marijuana research in the country.The Israelis have also been investigating the drug's ability to treat epilepsy, post-traumatic stress, cancer tumours, the side effects of chemotherapy, multiple sclerosis, Parkinson's and Tourette's syndrome, among others.'The Ministry of Health in Israel has channelled a lot of energy here in order to examine all the evidence based medicine, and is willing to take that approach,' Dr Gedo told The Times of India.'Other ministries of health around the world are hesitant.' Tetrahydrocannabinol (THC) is best known for being the psychoactive ingredient in marijuana. Both have drawn the attention of the medical community but it is CBD that has attracted most.BOL's new centre has a 35,000-square-foot plant, an 8,000-square-foot storage room, 30,000 square feet of grow rooms and labs, and a million square feet of cultivation fields.Bio-tech companies based there are preparing to expand production of the drug to meet rising global consumer demand.
One is Breath of Life Pharma (BOL), which is about to open the world's largest medical marijuana grow-house and research centre in central Israel.It is one of just three, along with Canada and the Netherlands, to have a government-sponsored cannabis program.